Zimmer Biomet Holdings (ZBH) said Monday it has completed its acquisition of medical device company Paragon 28.
Each Paragon 28 share was converted into the right to get $13 in cash and a non-tradeable contingent value right entitling holders to receive cash of up to $1 per share if certain revenue milestones are met, Zimmer Biomet said.
The company said shares of Paragon 28, which is now its wholly owned unit, ceased trading on the New York Stock Exchange before the market opened on Monday and will be delisted.
Price: 94.39, Change: -3.54, Percent Change: -3.61
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.